Brief: Graphite Bio Reports Recent Business Progress And Second Quarter 2022 Financial Results

LENZ Therapeutics

11/08/2022 21:42

Aug 11 (Reuters) - Graphite Bio Inc  GRPH.O :
    * GRAPHITE BIO REPORTS RECENT BUSINESS PROGRESS AND SECOND
QUARTER
2022 FINANCIAL RESULTS
    * CASH RUNWAY INTO Q4 2024
    * $328.3 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS
IN
MARKETABLE SECURITIES AS OF JUNE 30, 2022
    * QTRLY LOSS PER SHARE $0.48
    * Q2 EARNINGS PER SHARE VIEW $-0.49 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw94y1JJa 
Further company coverage:  GRPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))